Charles Schwab Investment Management Inc Eton Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,239 shares of ETON stock, worth $193,421. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,239
Previous 13,239
-0.0%
Holding current value
$193,421
Previous $79,000
120.25%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
74Shares Held
13.1MCall Options Held
284KPut Options Held
4.2K-
Opaleye Management Inc. Boston, MA2.85MShares$41.7 Million7.38% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.83MShares$26.7 Million1.12% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.12MShares$16.3 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$15.5 Million0.0% of portfolio
-
Westside Investment Management, Inc.575KShares$8.4 Million1.61% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $370M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...